BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9935020)

  • 1. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
    French JK; Amos DJ; Williams BF; Cross DB; Elliott JM; Hart HH; Williams MG; Norris RM; Ashton NG; Whitlock RM; McLaughlin SC; White HD
    J Am Coll Cardiol; 1999 Jan; 33(1):139-45. PubMed ID: 9935020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
    Amos DJ; French JK; Andrews J; Ashton NG; Williams BF; Whitlock RM; Manda SO; White HD
    Am Heart J; 2001 Apr; 141(4):586-91. PubMed ID: 11275924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.
    French JK; Hyde TA; Straznicky IT; Andrews J; Lund M; Amos DJ; Zambanini A; Ellis CJ; Webber BJ; McLaughlin SC; Whitlock RM; Manda SO; Patel H; White HD
    J Am Coll Cardiol; 2000 May; 35(6):1516-24. PubMed ID: 10807455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.
    French JK; Hyde TA; Patel H; Amos DJ; McLaughlin SC; Webber BJ; White HD
    J Am Coll Cardiol; 1999 Jul; 34(1):62-9. PubMed ID: 10399993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.
    Andrews J; Straznicky IT; French JK; Green CL; Maas AC; Lund M; Krucoff MW; White HD
    Circulation; 2000 May; 101(18):2138-43. PubMed ID: 10801752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Lundergan CF; Reiner JS; McCarthy WF; Coyne KS; Califf RM; Ross AM
    J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
    J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study (CATS).
    Kingma JH; van Gilst WH
    Herz; 1993 Dec; 18 Suppl 1():416-23. PubMed ID: 8125421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction.
    French JK; Straznicky IT; Webber BJ; Aylward PE; Frey MJ; Adgey AA; Williams BF; McLaughlin SC; White HD
    Heart; 1999 Feb; 81(2):128-33. PubMed ID: 9922346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials.
    Cerqueira MD; Maynard C; Ritchie JL; Davis KB; Kennedy JW
    J Am Coll Cardiol; 1992 Dec; 20(7):1452-9. PubMed ID: 1452917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.
    de Boer MJ; Suryapranata H; Hoorntje JC; Reiffers S; Liem AL; Miedema K; Hermens WT; van den Brand MJ; Zijlstra F
    Circulation; 1994 Aug; 90(2):753-61. PubMed ID: 8044944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
    J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
    French JK; Andrews J; Manda SO; Stewart RA; McTigue JJ; White HD
    Am Heart J; 2002 Feb; 143(2):265-71. PubMed ID: 11835029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
    van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M
    J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
    Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.